GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CYCN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Cyclerion TherapeuticsInc.
(Updated on Apr 18, 2024)

Buy candidate since Apr 16, 2024 Gain 1.20% PDF

No changes to the price of Cyclerion TherapeuticsInc. stock on the last trading day (Thursday, 18th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $3.22 to a day high of $3.22. The price has fallen in 6 of the last 10 days and is down by -5.07% for this period.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Cyclerion TherapeuticsInc. stock with a 90% probability to be traded between $2.88 and $4.06 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CYCN Signals & Forecast

The Cyclerion TherapeuticsInc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.21 and $3.14. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 1.20%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cyclerion TherapeuticsInc. stock

Cyclerion TherapeuticsInc. finds support from accumulated volume at $3.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 7.91%

Our recommended stop-loss: $3.04 (-5.55%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (CYCN) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Cyclerion TherapeuticsInc. to open at $3.22, and during the day (based on 14 day Average True Range), to move between $2.96 and $3.47, which gives a possible trading interval of +/-$0.256 (+/-7.95%) up or down from last closing price. If Cyclerion TherapeuticsInc. takes out the full calculated possible swing range there will be an estimated 15.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.20 (0.57%) than the resistance at $3.37 (4.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cyclerion TherapeuticsInc. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Cyclerion TherapeuticsInc. stock to perform well in the short-term period.

Current score: 2.588 Buy Candidate Unchanged

Predicted Opening Price for Cyclerion TherapeuticsInc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$3.22 ( 0%) $3.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CYCN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.22 .
R2 3.22 .
R1 3.22 .
Current price: 3.22
Support S1 3.22 .
S2 3.22 .
S3 3.22 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.94 22.43 %
R2 3.66 13.73 %
R1 3.37 4.72 %
Current price 3.22
Support S1 3.20 -0.566%
S2 3.01 -6.47%
S3 2.90 -9.89%

FAQ

What is the symbol for Cyclerion TherapeuticsInc. Stock and on which exchange is it traded?
The symbol for Cyclerion TherapeuticsInc. is CYCN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cyclerion TherapeuticsInc. Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Cyclerion TherapeuticsInc. stock to perform well in the short-term period.

How to buy Cyclerion TherapeuticsInc. Stock?
Cyclerion TherapeuticsInc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cyclerion TherapeuticsInc. Stock.

What's the current price of Cyclerion TherapeuticsInc. Stock?
As of the end of day on the 2024-04-18, the price of an Cyclerion TherapeuticsInc. (CYCN) share was $3.22.

What is the 52-week high and low for Cyclerion TherapeuticsInc. Stock?
The 52-week high for Cyclerion TherapeuticsInc. Stock is $6.75 and the 52-week low is $0.183.

What is the market capitalization of Cyclerion TherapeuticsInc. Stock?
As of the 2024-04-18, the market capitalization of Cyclerion TherapeuticsInc. is 8.722M.

When is the next earnings date for Cyclerion TherapeuticsInc.?
The upcoming earnings date for Cyclerion TherapeuticsInc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Cyclerion TherapeuticsInc.

Cyclerion TherapeuticsInc. Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis... CYCN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT